Single-cell Analysis Market - Global Forecast to 2028

The global single-cell analysis market size is projected to reach USD 7.1 billion by 2028 from USD 3.5 billion in 2023, at a CAGR of 15.3% during the forecast period.

Lists of Companies Profiled in the Report:

• Becton, Dickinson and Company (US)
• Danaher Corporation (US)
• Merck KGaA (Germany)
• QIAGEN N.V. (Netherlands)
• Thermo Fisher Scientific, Inc. (US)
• 10x Genomics (US)
• Promega Corporation (US)
• Illumina, Inc. (US)
• Bio-Rad Laboratories (US)
• Standard BioTools (US)
• Agilent Technologies, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• Sartorius AG (Germany)
• DiaSorin S.p.A. (Italy)
• Takara Bio, Inc. (Japan)
• Fluxion Biosciences (US)
• Menarini Silicon Biosystems Inc. (Italy)
• bioMérieux SA (France)
• Oxford Nanopore Technologies (UK)
• Cytek Biosciences (US)
• Corning Incorporated (US)
• Apogee Flow Systems Ltd. (UK)
• NanoCellect Biomedical (US)
• RareCyte, Inc. (US)
• On-chip Biotechnologies Co., Ltd. (Japan).

The single-cell analysis market refers to the field of research and technology focused on analyzing individual cells at the single-cell level, rather than studying them in bulk populations. This approach allows researchers to gain a deeper understanding of cellular heterogeneity and uncover unique characteristics of individual cells within a larger population.

Single-cell analysis has revolutionized various fields, including genomics, transcriptomics, proteomics, and metabolomics. It has enabled researchers to explore diverse cellular functions, identify rare cell types, investigate cellular interactions, and study disease mechanisms at a previously unimaginable resolution.

The market for single-cell analysis has been growing rapidly in recent years, driven by advancements in technology and increasing demand for more precise and detailed cellular analysis. Key technologies and techniques employed in single-cell analysis include single-cell RNA sequencing (scRNA-seq), single-cell proteomics, single-cell genomics, and single-cell imaging.

The market encompasses a range of products and services, including instruments (such as microfluidic devices and flow cytometers), consumables (such as reagents and assay kits), software solutions for data analysis, and specialized services for single-cell analysis. Several companies are actively involved in developing and commercializing products and platforms for single-cell analysis.

The single-cell analysis market finds applications in various fields, including cancer research, immunology, neurology, developmental biology, stem cell research, and personalized medicine. It has the potential to accelerate drug discovery and development, enable precision medicine approaches, and advance our understanding of complex biological systems.

Overall, the single-cell analysis market is expected to continue its growth trajectory as researchers increasingly recognize the value of studying cells at the single-cell level. Ongoing technological advancements, decreasing costs, and expanding applications are likely to drive further innovation and market expansion in the years to come.